And Tesamorelin reduces visceral fat… “Nonalcoholic fatty liver disease, or NAFLD, affects approximately 25% of the general adult population in the United States. But unfortunately, patients or people living with HIV are at a higher risk. Previous studies have shown that approximately 35% of HIV patients have evidence of NAFLD and that they tend to progress more rapidly in terms of fibrosis stages, which can lead to complications including the development of cirrhosis and possibly liver cancer. So, people with HIV are at a higher risk of developing fatty liver disease and progressing to more advanced forms of fatty liver.
When we think of different types of fat, we think of visceral fat or visceral adipose tissue compared to subcutaneous adipose tissue, and visceral adipose tissue is more metabolically active and can actually cause more fat deposition and release by the release of fatty acids through the portal circulation, and these free fatty acids can be deposited in the liver cells and lead to the formation of triglycerides and lipid droplets. And this is really the beginning of non-alcoholic fatty liver disease, which can lead to further liver inflammation, liver cell damage and eventually the development of liver fibrosis…”
https://letterspedia.com/the-relationship-between-waist-circumference-liver-disease/